Advertisement
Screener

Collegium Pharmaceutical, Inc. (COLL) Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3

2.8 / 5 stars · 68/120 Roast Me

Collegium Pharmaceutical, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3

Collegium Pharmaceutical, Inc. (COLL) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 · last filed 2025-11-06

  • Collegium Pharmaceutical, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-09-30 was $0.00.
  • Collegium Pharmaceutical, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-06-30 was $0.00.
  • Collegium Pharmaceutical, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-03-31 was $0.00.
  • Collegium Pharmaceutical, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2024-09-30 was $0.00.
  • Collegium Pharmaceutical, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2023 was $0.00.
  • Collegium Pharmaceutical, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2022 was $0.00.
  • Collegium Pharmaceutical, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2021 was $0.00.
  • Collegium Pharmaceutical, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2020 was $0.00.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 12 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 24 month
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2025-11-06
$0.00
10-Q · filed 2025-11-06
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
2025-03-31$0.00
10-Q · filed 2025-05-08
2024-12-31$0.00
10-K · filed 2025-02-27
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2025-11-06
$0.00
10-Q · filed 2025-11-06
$0.00
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
$0.00
derived: sum of 3 quarters · filed 2025-08-07
$0.00
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$0.00
10-Q · filed 2025-05-08
$0.00
derived: sum of 2 quarters · filed 2025-05-08
$0.00
derived: sum of 3 quarters · filed 2025-05-08
$0.00
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$0.00
derived: sum of 2 quarters · filed 2025-02-27
$0.00
derived: sum of 3 quarters · filed 2025-02-27
$0.00
10-K · filed 2025-02-27
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$0.00
derived: sum of 2 quarters · filed 2024-11-07
$0.00
10-Q · filed 2024-11-07
$0.00
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$0.00
10-Q · filed 2024-08-08
$0.00
derived: sum of 3 quarters · filed 2024-08-08
$0.00
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$0.00
10-Q · filed 2024-05-09
$0.00
derived: sum of 2 quarters · filed 2024-05-09
$0.00
derived: sum of 3 quarters · filed 2024-05-09
$0.00
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$0.00
derived: sum of 2 quarters · filed 2024-02-22
$0.00
derived: sum of 3 quarters · filed 2024-02-22
$0.00
10-K · filed 2024-02-22
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$0.00
derived: sum of 2 quarters · filed 2023-11-07
$0.00
10-Q · filed 2023-11-07
$0.00
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
$0.00
derived: sum of 3 quarters · filed 2023-08-03
$0.00
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31$0.00
10-Q · filed 2023-05-04
$0.00
derived: sum of 2 quarters · filed 2023-05-04
$0.00
derived: sum of 3 quarters · filed 2023-05-04
$0.00
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$0.00
derived: sum of 2 quarters · filed 2023-02-23
$0.00
derived: sum of 3 quarters · filed 2023-02-23
$0.00
10-K · filed 2023-02-23
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$0.00
derived: sum of 2 quarters · filed 2022-11-03
$0.00
10-Q · filed 2022-11-03
$0.00
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$0.00
10-Q · filed 2022-08-04
$0.00
derived: sum of 3 quarters · filed 2022-08-04
$0.00
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31$0.00
10-Q · filed 2022-05-10
$0.00
derived: sum of 2 quarters · filed 2022-05-10
$0.00
derived: sum of 3 quarters · filed 2022-05-10
$0.00
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$0.00
derived: sum of 2 quarters · filed 2022-02-24
$0.00
derived: sum of 3 quarters · filed 2022-02-24
$0.00
10-K · filed 2022-02-24
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$0.00
derived: sum of 2 quarters · filed 2021-11-04
$0.00
10-Q · filed 2021-11-04
$0.00
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$0.00
10-Q · filed 2021-08-05
$0.00
derived: sum of 3 quarters · filed 2021-08-05
$0.00
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$0.00
10-Q · filed 2021-05-06
$0.00
derived: sum of 2 quarters · filed 2021-05-06
$0.00
derived: sum of 3 quarters · filed 2021-05-06
$0.00
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$0.00
derived: sum of 2 quarters · filed 2021-02-25
$0.00
derived: sum of 3 quarters · filed 2021-02-25
$0.00
10-K · filed 2021-02-25
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$0.00
derived: sum of 2 quarters · filed 2020-11-05
$0.00
10-Q · filed 2020-11-05
$0.00
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$0.00
10-Q · filed 2020-08-05
$0.00
derived: sum of 3 quarters · filed 2020-08-05
$0.00
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$0.00
10-Q · filed 2020-05-07
$0.00
derived: sum of 2 quarters · filed 2020-05-07
$0.00
derived: sum of 3 quarters · filed 2020-05-07
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$0.00
derived: sum of 2 quarters · filed 2020-02-27
$0.00
10-K · filed 2020-02-27
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$0.00
10-Q · filed 2019-11-06
2018-06-30$0.00
10-Q · filed 2019-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
GERON CORP (GERN)United States$0.803B-12.14